We are live on ! Find out more
AVNS icon

Avanos Medical

349 hedge funds and large institutions have $1.29B invested in Avanos Medical in 2015 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 123 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

27% more capital invested

Capital invested by funds: $1.02B → $1.29B (+$271M)

1% less funds holding

Funds holding: 352349 (-3)

2% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 52

16% less call options, than puts

Call options by funds: $4.83M | Put options by funds: $5.74M

28% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 123

Holders
349
Holders Change
-3
Holders Change %
-0.85%
% of All Funds
9.16%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
51
Increased
88
Reduced
123
Closed
52
Calls
$4.83M
Puts
$5.74M
Net Calls
-$915K
Net Calls Change
+$3.31M
Name Holding Trade Value Shares
Change
Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
$9.42M -$2.7M -86,790 -24%
RFC
27
Russell Frank Company
Washington
$8.44M -$45.1K -1,450 -0.6%
AA
28
AQR Arbitrage
Connecticut
$8.38M +$7.8M +250,973 New
Charles Schwab
29
Charles Schwab
California
$7.89M +$1.28M +41,120 +21%
GC
30
Guggenheim Capital
Illinois
$7.79M -$1.68M -54,168 -19%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$7.03M -$4.45M -143,255 -40%
ERSOT
32
Employees Retirement System of Texas
Texas
$6.45M
Morgan Stanley
33
Morgan Stanley
New York
$6.42M -$2.96M -95,068 -33%
USAA
34
United Services Automobile Association
Texas
$6.41M +$5.97M +191,955 New
AQR Capital Management
35
AQR Capital Management
Connecticut
$5.97M +$2.73M +87,829 +97%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$5.44M +$435K +14,000 +9%
BG
37
BlackRock Group
United Kingdom
$5.2M +$3.46M +111,260 +250%
ABC
38
Associated Banc-Corp
Wisconsin
$5.14M -$28.4K -913 -0.6%
TCIM
39
TIAA CREF Investment Management
New York
$5.03M -$132K -4,232 -3%
PRCM
40
Pine River Capital Management
Minnesota
$5.01M +$4.66M +149,839 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$4.94M +$2.89M +92,791 +168%
Principal Financial Group
42
Principal Financial Group
Iowa
$4.94M +$336K +10,792 +8%
Deutsche Bank
43
Deutsche Bank
Germany
$4.35M +$2.99M +96,315 +283%
UBS Group
44
UBS Group
Switzerland
$4.29M -$2.57M -82,640 -39%
SEI Investments
45
SEI Investments
Pennsylvania
$4.25M -$871 -28 -0%
Ameriprise
46
Ameriprise
Minnesota
$4.1M -$96.3K -3,097 -2%
PPA
47
Parametric Portfolio Associates
Washington
$4.09M +$1.43M +45,888 +60%
AIG
48
American International Group
New York
$3.94M -$115K -3,687 -3%
Macquarie Group
49
Macquarie Group
Australia
$3.92M
NFA
50
Nationwide Fund Advisors
Ohio
$3.57M +$15.3K +493 +0.5%

AVNS Hedge Fund Activity: Q4 2015 in Review

349 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2015, worth a combined $1.29B — up 27% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of AVNS and 51 opened new positions — a net loss of 1 holder — while 123 trimmed existing stakes and 88 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $39.4M. The largest seller was RR Partners, exiting entirely with an estimated $17.9M sold.

  • 349 institutional investors held Avanos Medical (AVNS) as of Q4 2015, down from 352 in Q3 2015.
  • Funds reported $1.29B of Avanos Medical stock for Q4 2015, up 27% quarter-over-quarter.
  • 51 funds opened new Avanos Medical positions in Q4 2015 and 52 closed out, a net change of -1 holder.
  • The largest Avanos Medical buyer in Q4 2015 was T. Rowe Price Associates, an estimated $39.4M added.
  • The largest Avanos Medical seller in Q4 2015 was RR Partners, an estimated $17.9M sold.

Based on aggregated 13F filings for Q4 2015.